يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"V. G. Novoselov"', وقت الاستعلام: 0.40s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: The work was performed without external funding., Работа выполнена без спонсорской поддержки.

    المصدر: Cancer Urology; Том 18, № 4 (2022); 136-140 ; Онкоурология; Том 18, № 4 (2022); 136-140 ; 1996-1812 ; 1726-9776

    وصف الملف: application/pdf

    Relation: https://oncourology.abvpress.ru/oncur/article/view/1564/1426; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1564/1118; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1564/1119; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1564/1120; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1564/1121; Rawla P. Epidemiology of prostate cancer. World J Oncol 2019;10(2):63–89. DOI:10.14740/wjon1191; Litwin M.S., Tan H.J. The diagnosis and treatment of prostate cancer: a review. JAMA 2017;317(24):2532–42. DOI:10.1001/jama.2017.7248; Кельн А.А., Алифов Д.Г., Купчин А.В. Совершенствование скрининговых программ раннего выявления рака предстательной железы. Академический журнал Западной Сибири 2019;15(5 (82)):42–3.; Holm H.V., Dahl A.A., Klepp O.H., Fosså S.D. Modern treatment of metastatic prostate cancer. Tidsskr Nor Laegeforen 2017;137(11):803–5. DOI:10.4045/tidsskr.16.0265; Eng T.Y., Chen T.W., Patel A.J. et al. Treatment and outcomes of primary urethra cancer. Am J Clin Oncol 2018;41(9):905–8. DOI:10.1097/COC.0000000000000391; Aydin F. Endometrioid adenocarcinoma of prostatic urethra presenting with anterior urethral implantation. Urology 1993;41(1):91–5. DOI:10.1016/0090-4295(93)90255-9; Taylor G.B., McNeal J.E., Cohen R.J. Intraductal carcinoma of the prostate metastatic to the penile urethra: a rare demonstration of two morphologic patterns of tumor growth. Pathology 1998;30(2):218–21. DOI:10.1080/00313029800169306; Ohyama C., Takyu S., Yoshikawa K. et al. Adenocarcinoma arising from the prostatic duct mimicking transitional cell carcinoma. Int J Urol 2001;8(7):408–11. DOI:10.1046/j.1442-2042.2001.00323.x; Green J.M., Tang W.W., Jensen B.W., Orihuela E. Isolated recurrence of ductal prostate cancer to anterior urethra. Urology 2006;68(2):428.e13–5. DOI:10.1016/j.urology.2006.03.024; Dong X., Wang L., Taniguchi K. et al. Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 2003;72(2):270–80. DOI:10.1086/346094; Stolarova L., Kleiblova P., Janatova M. et al. CHEK2 germline variants in cancer predisposition: stalemate rather than checkmate. Cells 2020;9(12):2675. DOI:10.3390/cells9122675; Isaacsson Velho P., Silberstein J.L., Markowski M.C. et al. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer. Prostate 2018;78(5):401–7. DOI:10.1002/pros.23484; Giri V.N., Hegarty S.E., Hyatt C. et al. Germline genetic testing for inherited prostate cancer in practice: implications for genetic testing, precision therapy, and cascade testing. Prostate 2019;79(4):333–9. DOI:10.1002/pros.23739; Wu Y., Yu H., Zheng S.L. et al. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer. Prostate 2018;78(8):607–15. DOI:10.1002/pros.23505; Yadav S., Hu C., Hart S.N. et al. Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer. J Clin Oncol 2020;38(13):1409–18. DOI:10.1200/JCO.19.02190; https://oncourology.abvpress.ru/oncur/article/view/1564

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9